Collegium Pharmaceutical, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2002-01-01
- Employees
- 197
- Market Cap
- $1.2B
Collegium Provides 2025 Financial Guidance and Business Update
Collegium Pharmaceutical forecasts 2025 product revenues between $735M-$750M, with Jornay PM net revenue exceeding $135M. Adjusted EBITDA is projected at $435M-$450M, and adjusted operating expenses at $220M-$230M. The company aims for growth through Jornay PM and strategic capital deployment.
© Copyright 2025. All Rights Reserved by MedPath